{"nct_id":"NCT02843659","title":"Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome","status":"TERMINATED","status_verified_date":"2018-10","start_date":"2016-10-18","start_date_type":"ACTUAL","primary_completion_date":"2017-07-24","primary_completion_date_type":"ACTUAL","completion_date":"2017-07-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}